Genericart Prasugrel Hydrochloride 10mg Tablet

Introduction

Genericart Prasugrel Hydrochloride is a prescription medication that contains the active ingredient Prasugrel. It is commonly used to prevent blood clots in patients with acute coronary syndrome (ACS) who have undergone a procedure to open blocked arteries (such as angioplasty).

Uses

Genericart Prasugrel Hydrochloride is primarily prescribed for the prevention of blood clots in patients with ACS. It helps to reduce the risk of heart attack or stroke by preventing platelets in the blood from sticking together and forming clots.

Dosage and Administration

The dosage of Genericart Prasugrel Hydrochloride may vary depending on the specific condition and individual patient factors. Follow the instructions provided by your healthcare professional. Typically, the recommended dose is 60 mg orally, followed by a maintenance dose of 10 mg once daily. The tablet should be swallowed whole with or without food.

Mechanism of Action

Prasugrel, the active ingredient in Genericart Prasugrel Hydrochloride, belongs to a class of medications called platelet inhibitors. It works by blocking the activation of platelets, which are small cells in the blood involved in clot formation. By inhibiting platelet activation, Prasugrel helps to prevent the formation of blood clots that can lead to heart attack or stroke.

Side Effects

Common side effects may include bleeding, bruising, headache, and nausea. Serious side effects may include severe bleeding, such as gastrointestinal bleeding or bleeding in the brain. If you experience any unusual bleeding, black or bloody stools, or signs of a stroke (such as sudden weakness or numbness on one side of the body), seek immediate medical attention.

Drug Interactions

inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. Genericart Prasugrel Hydrochloride may interact with certain medications, such as other blood-thinning medications or nonsteroidal anti-inflammatory drugs (NSAIDs). These interactions can increase the risk of bleeding. Your healthcare professional will consider these potential interactions when prescribing Genericart Prasugrel Hydrochloride.

Precautions

Before taking Genericart Prasugrel Hydrochloride, inform your healthcare professional about any medical conditions you have, especially if you have a history of bleeding disorders or if you are scheduled for surgery. Genericart Prasugrel Hydrochloride should be used with caution in patients with a higher risk of bleeding. Avoid alcohol and certain substances, such as grapefruit, that may interact with the medication.

Storage

Genericart Prasugrel Hydrochloride should be stored at room temperature, away from moisture and heat. Keep the medication in its original packaging and out of reach of children. Do not use Genericart Prasugrel Hydrochloride beyond the expiration date printed on the packaging.

Patient Tips

• Take Genericart Prasugrel Hydrochloride exactly as prescribed by your healthcare professional.
• Do not stop taking the medication without consulting your healthcare professional, as this may increase the risk of blood clots.
• Inform your healthcare professional about any unusual bleeding or bruising, as well as any signs of a stroke.
• Carry a medical identification card or wear a bracelet indicating that you are taking Genericart Prasugrel Hydrochloride, in case of emergency.
• If you have any questions or concerns about the medication, consult your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Efient 10 mg film-coated tablets (Health Professionals SmPC) Available at:
• Prasugrel (Drugs.com) [Accessed 27 Jun. 2024] (online) Available at:
• prasugrel tablet (RX) [Accessed 3 Jun. 2024] (online) Available at:
• Prasugrel (MedlinePlus) [Accessed 0 Jun. 2024] (online) Available at:
• Dogan Z, Yurtdas M, Bektasoglu G. Prasugrel-related hepatotoxicity. J Pak Med Assoc. 2022 Nov;72(11):2295-2297. doi: 10.47391/JPMA.3179. [Accessed 18 Jun. 2024] Available at: